Penser Access by Carnegie: Interview with Ascelia Pharma - Carnegie Investment Bank - Feb 21th 2024
We have interviewed the CEO and Vice CEO of Ascelia Pharma to provide an update on the company's status. Topline data for the company's lead project, Orviglance, is expected in May.
Find the interview on Penser Play: https://youtu.be/HIue6f9vhDU?si=I05Auv-199WNGEFp
This is a press release from Carnegie Investment Bank. Read more here: https://epaccess.penser.se/